Advisory Services Network, LLC Agios Pharmaceuticals, Inc. Transaction History

Advisory Services Network, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$19.97 - $24.53 $6,989 - $8,585	350 New	350 $7,000
Q4 2022 Feb 13, 2023	BUY	$24.81 - $31.52 $8,683 - $11,032	350 New	350 $9,000
Q3 2021 Nov 05, 2021	SELL	$41.92 - $58.18 $8,384 - $11,636	-200 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$52.06 - $61.27 $10,412 - $12,254	200 New	200 $11,000
Q1 2021 May 24, 2021	SELL	$44.23 - $57.5 $8,846 - $11,500	-200 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$33.21 - $46.54 $26,568 - $37,232	-800 Reduced 80.0%	200 $9,000
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $33,870 - $55,930	1,000 New	1,000 $35,000
Q2 2020 Aug 10, 2020	SELL	$34.45 - $53.48 $34,450 - $53,480	-1,000 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$30.08 - $50.59 $27,673 - $46,542	920 Added 1150.0%	1,000 $48,000
Q4 2017 Feb 08, 2018	BUY	$52.12 - $72.33 $2,606 - $3,616	50 Added 166.67%	80 $5,000
Q2 2017 Aug 17, 2017	BUY	N/A	30	30 $2,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.